151 related articles for article (PubMed ID: 34918336)
1. The prognosis of late-onset anti-N-methyl-D-aspartate receptor encephalitis in China.
Sun Y; Ren G; Ren J; Shan W; Han X; Lian Y; Wang T; Wang Q
Acta Neurol Scand; 2022 Apr; 145(4):449-455. PubMed ID: 34918336
[TBL] [Abstract][Full Text] [Related]
2. Paroxysmal Sympathetic Hyperactivity in Severe Anti-N-Methyl-d-Aspartate Receptor Encephalitis: A Single Center Retrospective Observational Study.
Wang D; Su S; Tan M; Wu Y; Wang S
Front Immunol; 2021; 12():665183. PubMed ID: 33912193
[TBL] [Abstract][Full Text] [Related]
3. Use and Safety of Immunotherapeutic Management of N-Methyl-d-Aspartate Receptor Antibody Encephalitis: A Meta-analysis.
Nosadini M; Eyre M; Molteni E; Thomas T; Irani SR; Dalmau J; Dale RC; Lim M; ; Anlar B; Armangue T; Benseler S; Cellucci T; Deiva K; Gallentine W; Gombolay G; Gorman MP; Hacohen Y; Jiang Y; Lim BC; Muscal E; Ndondo A; Neuteboom R; Rostásy K; Sakuma H; Sartori S; Sharma S; Tenembaum SN; Van Mater HA; Wells E; Wickstrom R; Yeshokumar AK
JAMA Neurol; 2021 Nov; 78(11):1333-1344. PubMed ID: 34542573
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics and long-term prognosis of relapsing anti-N-methyl-D-aspartate receptor encephalitis: a retrospective, multicenter, self-controlled study.
Zeng W; Cao L; Zheng J; Yu L
Neurol Sci; 2021 Jan; 42(1):199-207. PubMed ID: 32601745
[TBL] [Abstract][Full Text] [Related]
5. Factors influencing prognosis and relapse in patients with anti-N-methyl-D-aspartate receptor encephalitis.
Wu Q; Xie Q; Liu L; Meng C; Wang J
Mult Scler Relat Disord; 2023 Jun; 74():104697. PubMed ID: 37031550
[TBL] [Abstract][Full Text] [Related]
6. The Association Between Age and Prognosis in Patients Under 45 Years of Age With Anti-NMDA Receptor Encephalitis.
Sun Y; Ren G; Ren J; Shan W; Han X; Lian Y; Wang T; Wang Q
Front Neurol; 2020; 11():612632. PubMed ID: 33447251
[TBL] [Abstract][Full Text] [Related]
7. Assessment of long-term psychosocial outcomes in anti-NMDA receptor encephalitis.
Blum RA; Tomlinson AR; Jetté N; Kwon CS; Easton A; Yeshokumar AK
Epilepsy Behav; 2020 Jul; 108():107088. PubMed ID: 32375094
[TBL] [Abstract][Full Text] [Related]
8. EEG Findings May Serve as a Potential Biomarker for Anti-NMDA Receptor Encephalitis.
Foff EP; Taplinger D; Suski J; Lopes MB; Quigg M
Clin EEG Neurosci; 2017 Jan; 48(1):48-53. PubMed ID: 27068513
[TBL] [Abstract][Full Text] [Related]
9. Younger Age at Onset Is Associated With Worse Long-term Behavioral Outcomes in Anti-NMDA Receptor Encephalitis.
Yeshokumar A; Gordon-Lipkin E; Arenivas A; Rosenfeld M; Patterson K; Blum R; Banwell B; Venkatesan A; Lancaster E; Panzer J; Probasco J
Neurol Neuroimmunol Neuroinflamm; 2022 Sep; 9(5):. PubMed ID: 35794025
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal Disability, Cognitive Impairment, and Mood Symptoms in Patients With Anti-NMDA Receptor Encephalitis.
Morgan A; Li Y; Thompson NR; Milinovich A; Abbatemarco JR; Cohen JA; Ontaneda D; Punia V; Rae-Grant A; Galioto R; Kunchok A
Neurology; 2024 Feb; 102(4):e208019. PubMed ID: 38266213
[TBL] [Abstract][Full Text] [Related]
11. NMDA-receptor encephalitis in Denmark from 2009 to 2019: a national cohort study.
Nissen MS; Ørvik MS; Nilsson AC; Ryding M; Lydolph M; Blaabjerg M
J Neurol; 2022 Mar; 269(3):1618-1630. PubMed ID: 34351472
[TBL] [Abstract][Full Text] [Related]
12. Late-onset anti-N-methyl-d-aspartate receptor encephalitis in China.
Zhang L; Liu X; Jiang XY; Wang YH; Li JM; Zhou D
Epilepsy Behav; 2018 Jul; 84():22-28. PubMed ID: 29734104
[TBL] [Abstract][Full Text] [Related]
13. Sleep Characteristics in Pediatric Anti-
Gombolay G; Morris M; Loerinc L; Blackwell L; Howarth R
J Child Neurol; 2023 Apr; 38(5):298-306. PubMed ID: 37203168
[No Abstract] [Full Text] [Related]
14. Age-dependent characteristics and prognostic factors of pediatric anti-N-methyl-d-aspartate receptor encephalitis in a Chinese single-center study.
Zhang W; Ren C; Wang X; Li J; Ding C; Han T; Lv J; Chen C; Gong S; Xiuwei Z; Dai L; Feng W; Yang X; Zhang S; Zhou J; Ren H; Guan H; Ren X; Fang F
Eur J Paediatr Neurol; 2021 Sep; 34():67-73. PubMed ID: 34399369
[TBL] [Abstract][Full Text] [Related]
15. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis.
Fan S; Xu Y; Ren H; Guan H; Feng F; Gao X; Ding D; Fang F; Shan G; Guan T; Zhang Y; Dai Y; Yao M; Peng B; Zhu Y; Cui L
Mult Scler Relat Disord; 2018 Feb; 20():144-152. PubMed ID: 29414288
[TBL] [Abstract][Full Text] [Related]
16. [Electroencephalogram Features of Anti-N-Methyl-D-Aspartate Receptor Encephalitis and Their Value for Clinical Assessment].
Pan XY; Chen GH; Ning YP; He ZL; Pan NN; Hu YC; Liao XZ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):293-297. PubMed ID: 36949688
[TBL] [Abstract][Full Text] [Related]
17. Long-term Functional Outcomes and Relapse of Anti-NMDA Receptor Encephalitis: A Cohort Study in Western China.
Gong X; Chen C; Liu X; Lin J; Li A; Guo K; Zhou D; Hong Z
Neurol Neuroimmunol Neuroinflamm; 2021 Mar; 8(2):. PubMed ID: 33589542
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of clinical relapses and patient-oriented long-term outcomes of patients with anti-N-methyl-D-aspartate receptor encephalitis.
Hirose S; Hara M; Kamei S; Dalmau J; Nakajima H
J Neurol; 2022 May; 269(5):2486-2492. PubMed ID: 34613453
[TBL] [Abstract][Full Text] [Related]
19. Retrospective Pediatric Cohort Study Validates NEOS Score and Demonstrates Applicability in Children With Anti-NMDAR Encephalitis.
Nikolaus M; Rausch P; Rostásy K; Bertolini A; Wickström R; Johannsen J; Denecke J; Breu M; Schimmel M; Diepold K; Haeusler M; Quade A; Berger A; Rosewich H; Steen C; von Au K; Dreesmann M; Finke C; Bartels F; Kaindl AM; Schuelke M; Knierim E
Neurol Neuroimmunol Neuroinflamm; 2023 May; 10(3):. PubMed ID: 36948591
[TBL] [Abstract][Full Text] [Related]
20. Relapse factors of patients of anti-N-methyl-D-aspartate receptor encephalitis.
Zhao YY; Wang HX; Wang M; Yuan B; Sun TW; Xu YM
Acta Neurol Scand; 2022 Apr; 145(4):434-441. PubMed ID: 34927233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
